| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |